Skip to Content
Is it Exocrine Pancreatic Insufficiency? Get more info

Zantac Cool Mint

Pronunciation

Generic Name: ranitidine
Dosage Form: tablet, coated

Drug Facts

Active ingredient (in each tablet) Purpose
Ranitidine 150 mg (as ranitidine hydrochloride 168 mg).............................................................................................................................. Acid reducer

Uses

  • relieves heartburn associated with acid indigestion and sour stomach
  • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Warnings

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

Do not use

  • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
  • with other acid reducers
  • if you have kidney disease, except under the advice and supervision of a doctor

Ask a doctor before use if you have

  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating or dizziness
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
  • frequent chest pain
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomiting
  • stomach pain

Stop use and ask a doctor if

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days

If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • adults and children 12 years and over:
    • to relieve symptoms, swallow 1 tablet with a glass of water
    • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
    • can be used up to twice daily (do not take more than 2 tablets in 24 hours)
    • do not chew tablet
  • children under 12 years: ask a doctor

Other information

  • do not use if printed foil under bottle cap is open or torn (bottles)
  • do not use if individual blister unit is open or torn (blisters)
  • do not use if individual foil packet is open or torn (pouch)
  • store at 20-25ºC (68-77ºF)
  • avoid excessive heat or humidity
  • this product is sodium and sugar free

Inactive ingredients FD&C Blue No.1, flavors, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sucralose, titanium dioxide

Questions? call 1-888-285-9159 (English/Spanish) M – F, 8:30 – 5 EST, or visit www.zantacotc.com

Read the directions, consumer information leaflet and warnings before use. Keep the carton. It contains important information.

Distributed by: Boehringer Ingelheim (BI) Consumer Health Care Products
Division of BI Pharmaceuticals, Inc., Ridgefield, CT 06877
© 2016, BI Pharmaceuticals, Inc. All rights reserved.
Product of Spain. Manufactured in Mexico.

Zantac 150 mg Cool Mint - 24 Count Carton

Zantac 150 mg Cool Mint - 65 Count Carton

ZANTAC MAXIMUM STRENGTH 150 COOL MINT 
ranitidine tablet, coated
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:0597-0120
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ranitidine hydrochloride (ranitidine) ranitidine 150 mg
Inactive Ingredients
Ingredient Name Strength
FD&C BLUE NO. 1  
hypromelloses  
magnesium stearate  
cellulose, microcrystalline  
polyethylene glycols  
polysorbate 80  
sucralose  
titanium dioxide  
Product Characteristics
Color BLUE Score no score
Shape PENTAGON (5 sided) Size 4mm
Flavor MINT Imprint Code Z;150
Contains         
Packaging
# Item Code Package Description
1 NDC:0597-0120-06 1 BLISTER PACK in 1 CARTON
1 3 TABLET, COATED in 1 BLISTER PACK
2 NDC:0597-0120-08 1 TABLET, COATED in 1 POUCH
3 NDC:0597-0120-09 4 BLISTER PACK in 1 CARTON
3 8 TABLET, COATED in 1 BLISTER PACK
4 NDC:0597-0120-24 3 BLISTER PACK in 1 CARTON
4 8 TABLET, COATED in 1 BLISTER PACK
5 NDC:0597-0120-38 1 BLISTER PACK in 1 CARTON
5 8 TABLET, COATED in 1 BLISTER PACK
6 NDC:0597-0120-50 1 BOTTLE in 1 CARTON
6 50 TABLET, COATED in 1 BOTTLE
7 NDC:0597-0120-68 1 BOTTLE in 1 CARTON
7 65 TABLET, COATED in 1 BOTTLE
8 NDC:0597-0120-80 80 POUCH in 1 CARTON
8 1 TABLET, COATED in 1 POUCH
9 NDC:0597-0120-82 80 POUCH in 1 CARTON
9 1 TABLET, COATED in 1 POUCH
10 NDC:0597-0120-87 1 BOTTLE in 1 CARTON
10 85 TABLET, COATED in 1 BOTTLE
11 NDC:0597-0120-78 1 BOTTLE in 1 CARTON
11 78 TABLET, COATED in 1 BOTTLE
12 NDC:0597-0120-76 2 BLISTER PACK in 1 CARTON
12 8 TABLET, COATED in 1 BLISTER PACK
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021698 12/21/2006
Labeler - Boehringer Ingelheim Pharmaceuticals Inc. (603175944)
Registrant - Boehringer Ingelheim Pharmaceuticals Inc. (603175944)
Establishment
Name Address ID/FEI Operations
Patheon Manufacturing Services LLC 079415560 MANUFACTURE(0597-0120)
Establishment
Name Address ID/FEI Operations
Boehringer Ingelheim Promeco S.A de C.V. 812579472 LABEL(0597-0120), PACK(0597-0120), MANUFACTURE(0597-0120), ANALYSIS(0597-0120)
Revised: 12/2015
 
Boehringer Ingelheim Pharmaceuticals Inc.



Hide